Home / Journals / OR / Journal Overview

Journal Overview

Oncology Research: Featuring Preclinical and Clinical Cancer Therapeutics

ISSN: 0965-0407 (Print)

ISSN: 1555-3906 (Online)


Aims & Scope

Oncology Research: Featuring Preclinical and Clinical Cancer Therapeutics is committed to publishing high-quality, innovative research that is focused on the entire range of preclinical, translational, and clinical cancer therapeutics.      

Specific areas of interest include preclinical and translational research in development of novel small molecules and targeted therapies; mechanisms of drug sensitivity; mechanisms of cellular drug resistance; biomarkers of response and/or resistance; novel experimental model systems and technologies relating to cancer therapeutics; pharmacogenetics and pharmacogenomics; personalized medicine; immunotherapy and clinical immunology; gene therapy; and radiobiology and novel approaches to radiation therapy either alone or in combination with chemotherapy. For studies that investigate the role of microRNAs and non-coding RNAs as regulators of cellular gene expression, it will be important for more in-depth mechanistic studies to be conducted that confirm their biological activity and their potential effect as mediators of chemosensitivity. As part of the preclinical cancer therapeutics focus, the journal also prioritizes preclinical studies that are focused on drug design, chemical biology, and drug screening. While the journal’s primary focus is on small molecules and protein drugs, other molecular entities may be considered. In addition, submissions that investigate the potential role of herbal/botanical medicines in preclinical and clinical cancer therapy are welcomed; however, it will be important to document that these medicines are of high quality, with confirmation of batch-to-batch consistency. In addition to original peer-reviewed articles, the journal also welcomes timely reviews and/or commentaries on topics that focus on preclinical, translational, and/or clinical cancer therapeutics.


Applicable Readers

Oncology Research is targeted at medical and health workers engaged in cancer prevention, treatment and research, teachers and students from medical colleges and universities, and personnel in other related disciplines.


Publication Frequency

Bi-monthly


Ownership

The journal is owned by Tech Science Press.


Open Access

Oncology Research is an open access journal providing free, unrestricted online access to publisher content, open to all, with no access fees charged to the user and/or his/her institution.

Content can be read, downloaded, copied, distributed, printed, searched, linked to full text of articles and/or use for any other lawful purpose without obtaining permission from the publisher or author in accordance with the BOAI definition of open access. For further information, please refer to the Open Access Policy.


Archiving

All journals published by TSP are archived in Portico, which provides permanent digital archiving for scholarly journals.

Former publications (1992-2021) of this journal are available online archived in Ingenta Connect.


Ethics Statement

Oncology Research follows the standards of ICMJE. TSP takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure adding the highest quality scientific works to the field of scholarly publication. TSP takes such publishing ethics issues very seriously on every level. Our staff are trained to identify and report any irregularities. Our editors proceed with a zero-tolerance policy, to enforce COPE’s Core Practices and Guidelines and swiftly handle complex cases of plagiarism, data falsification, authorship credit, and the like.

Share Link

WeChat scan